Clinical Trial

Pharmacological and Behavioral Treatment After Bariatric Surgery

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study will compare the effectiveness of behavioral and pharmacologic treatment, alone and combined, for improvements in weight loss, cardiovascular risk factors, and psychosocial functioning following metabolic and bariatric surgery.
Trial Details
NCT Number NCT05157698
Lead Sponsor Yale University
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions Obesity
Enrollment 84 participants
Start Date 2022-01-13
Primary Completion 2027-01-12 (estimated)
Study Completion 2028-01-12 (estimated)
Updated on ClinicalTrials.gov 2026-06-10